1.
Full Text
International Congress of Drug Therapy in HIV Infection 23‐26 October 2016, Glasgow, UK
Journal of the International AIDS Society, ISSN 1758-2652, 10/2016, Volume 19, Issue 8(Suppl 7), pp. 21487 - n/a
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2014, Volume 370, Issue 5, pp. 433 - 443
In this study, the level of the chemokine CXCL4, which is secreted by plasmacytoid dendritic cells, was elevated in patients with systemic sclerosis and...
CELLS | MEDICINE, GENERAL & INTERNAL | ACTIVATION | REVISED CRITERIA | I INTERFERONS | DISEASE | LUPUS-ERYTHEMATOSUS | CLASSIFICATION | PLATELET-FACTOR-4 | SCLERODERMA SKIN | ASSOCIATION | Scleroderma, Systemic - blood | Cytokines - metabolism | Humans | Mice, Inbred C57BL | Middle Aged | Familial Primary Pulmonary Hypertension | Male | Proteome | Pulmonary Fibrosis - blood | Biomarkers - blood | Hypertension, Pulmonary - blood | RNA, Messenger - metabolism | Dendritic Cells - secretion | Animals | Scleroderma, Systemic - etiology | Platelet Factor 4 - secretion | Adult | Female | Mice | Platelet Factor 4 - blood | Skin - pathology | Hypertension | Phenotypes | Dendritic cells | Pathogenesis | Lung diseases | Liver | Arthritis | Inflammation | Gene expression | Patients | Studies | Spondylitis | Cell activation | Systemic lupus erythematosus | Systemic sclerosis | Fibrosis | Toll-like receptors | Plasma levels | Skin | Interferon | Autoimmune diseases | Scleroderma | Ankylosing spondylitis | Chemokines
CELLS | MEDICINE, GENERAL & INTERNAL | ACTIVATION | REVISED CRITERIA | I INTERFERONS | DISEASE | LUPUS-ERYTHEMATOSUS | CLASSIFICATION | PLATELET-FACTOR-4 | SCLERODERMA SKIN | ASSOCIATION | Scleroderma, Systemic - blood | Cytokines - metabolism | Humans | Mice, Inbred C57BL | Middle Aged | Familial Primary Pulmonary Hypertension | Male | Proteome | Pulmonary Fibrosis - blood | Biomarkers - blood | Hypertension, Pulmonary - blood | RNA, Messenger - metabolism | Dendritic Cells - secretion | Animals | Scleroderma, Systemic - etiology | Platelet Factor 4 - secretion | Adult | Female | Mice | Platelet Factor 4 - blood | Skin - pathology | Hypertension | Phenotypes | Dendritic cells | Pathogenesis | Lung diseases | Liver | Arthritis | Inflammation | Gene expression | Patients | Studies | Spondylitis | Cell activation | Systemic lupus erythematosus | Systemic sclerosis | Fibrosis | Toll-like receptors | Plasma levels | Skin | Interferon | Autoimmune diseases | Scleroderma | Ankylosing spondylitis | Chemokines
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 12/2017, Volume 69, Issue 12, pp. 2359 - 2369
OBJECTIVE: Patients with definite systemic sclerosis (SSc) who lack fibrotic features can be stratified into an intermediate stage of disease severity between...
Severity of Illness Index | Humans | Middle Aged | Male | Case-Control Studies | Chemokine CXCL11 | Disease Progression | Journal Article | Chemokine CXCL10 | Chitinase-3-Like Protein 1 | Receptors, Tumor Necrosis Factor, Type II | Fibrosis | Scleroderma, Systemic | Biomarkers | Adult | Female | Pulmonary Fibrosis | CRITERIA | INHIBITION | DISEASE SEVERITY | CLASSIFICATION | MICROVASCULAR DAMAGE | LIGAND | SKIN | RHEUMATOLOGY | YKL-40 | PROGRESSION | Chemokine CXCL10 - blood | Scleroderma, Systemic - blood | Scleroderma, Systemic - pathology | Pulmonary Fibrosis - blood | Biomarkers - blood | Receptors, Tumor Necrosis Factor, Type II - blood | Scleroderma, Systemic - complications | Chitinase-3-Like Protein 1 - blood | Chemokine CXCL11 - blood | Pulmonary Fibrosis - etiology | Chitinase | Immunoassay | Inflammation | Criteria | Disease control | Patients | Proteins | Lungs | Systemic sclerosis | CXCL10 protein | Replication | Skin | Interception | CXCL11 protein
Severity of Illness Index | Humans | Middle Aged | Male | Case-Control Studies | Chemokine CXCL11 | Disease Progression | Journal Article | Chemokine CXCL10 | Chitinase-3-Like Protein 1 | Receptors, Tumor Necrosis Factor, Type II | Fibrosis | Scleroderma, Systemic | Biomarkers | Adult | Female | Pulmonary Fibrosis | CRITERIA | INHIBITION | DISEASE SEVERITY | CLASSIFICATION | MICROVASCULAR DAMAGE | LIGAND | SKIN | RHEUMATOLOGY | YKL-40 | PROGRESSION | Chemokine CXCL10 - blood | Scleroderma, Systemic - blood | Scleroderma, Systemic - pathology | Pulmonary Fibrosis - blood | Biomarkers - blood | Receptors, Tumor Necrosis Factor, Type II - blood | Scleroderma, Systemic - complications | Chitinase-3-Like Protein 1 - blood | Chemokine CXCL11 - blood | Pulmonary Fibrosis - etiology | Chitinase | Immunoassay | Inflammation | Criteria | Disease control | Patients | Proteins | Lungs | Systemic sclerosis | CXCL10 protein | Replication | Skin | Interception | CXCL11 protein
Journal Article
Arthritis and Rheumatology, ISSN 2326-5191, 2019, Volume 71, Issue 10, pp. 1711 - 1722
Objective: To analyze the potential role of semaphorin 4A (Sema4A) in inflammatory and fibrotic processes involved in the pathology of systemic sclerosis...
Flow cytometry | Helper cells | Confocal microscopy | Lymphocytes T | Assaying | CD28 antigen | Western blotting | Receptors | Lymphocytes | Fibroblasts | Extracellular matrix | Enzyme-linked immunosorbent assay | Phenotypes | Cytokines | Secretion | Therapeutic applications | CD3 antigen | Inflammation | CD4 antigen | Polymerase chain reaction | Monocytes | Microscopy | Systemic sclerosis | Fibrosis | Plasma levels | Skin
Flow cytometry | Helper cells | Confocal microscopy | Lymphocytes T | Assaying | CD28 antigen | Western blotting | Receptors | Lymphocytes | Fibroblasts | Extracellular matrix | Enzyme-linked immunosorbent assay | Phenotypes | Cytokines | Secretion | Therapeutic applications | CD3 antigen | Inflammation | CD4 antigen | Polymerase chain reaction | Monocytes | Microscopy | Systemic sclerosis | Fibrosis | Plasma levels | Skin
Journal Article
Neurological Sciences, ISSN 1590-1874, 9/2018, Volume 39, Issue 9, pp. 1613 - 1615
Neurology | Neurosurgery | Medicine & Public Health | Psychiatry | Neuroradiology | NEUROSCIENCES | CLINICAL NEUROLOGY | Polyomavirus Infections - complications | Brain - diagnostic imaging | Diagnosis, Differential | Lupus Erythematosus, Systemic - complications | Humans | Middle Aged | Tumor Virus Infections - diagnosis | Male | Leukoencephalopathy, Progressive Multifocal - diagnosis | Polyomavirus Infections - pathology | BK Virus | Lupus Erythematosus, Systemic - diagnosis | Tumor Virus Infections - complications | Polyomavirus Infections - diagnosis | Fatal Outcome | Brain - pathology | Leukoencephalopathy, Progressive Multifocal - pathology | Lupus Erythematosus, Systemic - pathology | Tumor Virus Infections - pathology | Leukoencephalopathy, Progressive Multifocal - complications | Leukoencephalitis | Systemic lupus erythematosus
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 02/2018, Volume 233, Issue 2, pp. 1736 - 1751
Metformin (MET) is the drug of choice for patients with type 2 diabetes and has been proposed for use in cancer therapy and for treating other metabolic...
metformin | energetic metabolism | Fanconi anemia | cancerogenesis | oxidative stress | POLYCYSTIC-OVARY-SYNDROME | PHYSIOLOGY | MITOCHONDRIAL ACTIVITY | PROTECTION | CLINICAL PHARMACOKINETICS | CANCER | DEFICIENCY | CELL BIOLOGY | BIOGENESIS | COMPLEX I DEFECTS | EXPRESSION | Lymphocytes - metabolism | Sirtuin 1 - metabolism | Cell Survival - drug effects | AMP-Activated Protein Kinases - metabolism | Leukemia - pathology | Fanconi Anemia - metabolism | Humans | Metformin - pharmacology | Leukemia - drug therapy | Leukemia - metabolism | Metformin - toxicity | Case-Control Studies | Dose-Response Relationship, Drug | Oxidative Phosphorylation - drug effects | Lymphocytes - pathology | Lymphocytes - drug effects | HL-60 Cells | Fanconi Anemia - pathology | DNA Damage | Enzyme Activation | Oxidative Stress - drug effects | Fanconi Anemia - drug therapy | Energy Metabolism - drug effects | Type 2 diabetes | Glucose metabolism | Medical research | DNA damage | Analysis | Leukemia | Medicine, Experimental | Hypoglycemic agents | Fanconi's anemia | Oxidative stress | Phosphorylation | Low concentrations | Anemia | Diabetes mellitus | Cytology | Tumor cell lines | Metabolism | Fanconi syndrome | Patients | SIRT1 protein | DNA repair | Cell morphology | Promyeloid leukemia | Oxidative phosphorylation | Drug metabolism | Metformin | Electron transport | Metabolic disorders | Deoxyribonucleic acid--DNA | Cancer | Index Medicus
metformin | energetic metabolism | Fanconi anemia | cancerogenesis | oxidative stress | POLYCYSTIC-OVARY-SYNDROME | PHYSIOLOGY | MITOCHONDRIAL ACTIVITY | PROTECTION | CLINICAL PHARMACOKINETICS | CANCER | DEFICIENCY | CELL BIOLOGY | BIOGENESIS | COMPLEX I DEFECTS | EXPRESSION | Lymphocytes - metabolism | Sirtuin 1 - metabolism | Cell Survival - drug effects | AMP-Activated Protein Kinases - metabolism | Leukemia - pathology | Fanconi Anemia - metabolism | Humans | Metformin - pharmacology | Leukemia - drug therapy | Leukemia - metabolism | Metformin - toxicity | Case-Control Studies | Dose-Response Relationship, Drug | Oxidative Phosphorylation - drug effects | Lymphocytes - pathology | Lymphocytes - drug effects | HL-60 Cells | Fanconi Anemia - pathology | DNA Damage | Enzyme Activation | Oxidative Stress - drug effects | Fanconi Anemia - drug therapy | Energy Metabolism - drug effects | Type 2 diabetes | Glucose metabolism | Medical research | DNA damage | Analysis | Leukemia | Medicine, Experimental | Hypoglycemic agents | Fanconi's anemia | Oxidative stress | Phosphorylation | Low concentrations | Anemia | Diabetes mellitus | Cytology | Tumor cell lines | Metabolism | Fanconi syndrome | Patients | SIRT1 protein | DNA repair | Cell morphology | Promyeloid leukemia | Oxidative phosphorylation | Drug metabolism | Metformin | Electron transport | Metabolic disorders | Deoxyribonucleic acid--DNA | Cancer | Index Medicus
Journal Article
Stem Cell Reports, ISSN 2213-6711, 06/2016, Volume 6, Issue 6, pp. 897 - 913
A widely shared view reads that mesenchymal stem/stromal cells ("MSCs") are ubiquitous in human connective tissues, can be defined by a common in vitro...
mesenchymal stem cell | differentiation | bone marrow stromal cell | skeletal progenitors | hematopoietic microenvironment | transplantation | in vivo assays | myogenic progenitors | Chondrogenesis - genetics | Humans | Pericytes - cytology | Microvessels - metabolism | Transcriptome | Transplantation, Heterologous | Gene Expression Profiling | Mesenchymal Stromal Cells - cytology | Cell Differentiation | Cell Lineage - genetics | Osteogenesis - genetics | Biomarkers - metabolism | Microvessels - cytology | Gene Expression | Bone Marrow Cells - cytology | Pericytes - metabolism | Satellite Cells, Skeletal Muscle - cytology | Mesenchymal Stromal Cells - metabolism | Satellite Cells, Skeletal Muscle - metabolism | Fetal Blood - cytology | Fetal Blood - metabolism | Phenotype | Animals | Mice | Bone Marrow Cells - metabolism | Mesenchymal Stem Cell Transplantation
mesenchymal stem cell | differentiation | bone marrow stromal cell | skeletal progenitors | hematopoietic microenvironment | transplantation | in vivo assays | myogenic progenitors | Chondrogenesis - genetics | Humans | Pericytes - cytology | Microvessels - metabolism | Transcriptome | Transplantation, Heterologous | Gene Expression Profiling | Mesenchymal Stromal Cells - cytology | Cell Differentiation | Cell Lineage - genetics | Osteogenesis - genetics | Biomarkers - metabolism | Microvessels - cytology | Gene Expression | Bone Marrow Cells - cytology | Pericytes - metabolism | Satellite Cells, Skeletal Muscle - cytology | Mesenchymal Stromal Cells - metabolism | Satellite Cells, Skeletal Muscle - metabolism | Fetal Blood - cytology | Fetal Blood - metabolism | Phenotype | Animals | Mice | Bone Marrow Cells - metabolism | Mesenchymal Stem Cell Transplantation
Journal Article
International Journal of Food Sciences and Nutrition, ISSN 0963-7486, 08/2018, Volume 69, Issue 6, pp. 676 - 681
Breakfast foods with lower glycaemic responses are associated with better body weight control. Glycaemic index (GI) values of some commonly consumed breakfast...
Breakfast | nutrition | Italian | glycaemic index | METAANALYSIS | ADULT-POPULATION | FOOD SCIENCE & TECHNOLOGY | CARBOHYDRATE | FOODS | INSULIN | RESPONSES | OBESITY | NUTRITION & DIETETICS | FAT | PLASMA-GLUCOSE | CONSUMPTION | Breakfast foods | Cakes | Body weight | Pastries | Glycemic index | Sugar | Bread | Food
Breakfast | nutrition | Italian | glycaemic index | METAANALYSIS | ADULT-POPULATION | FOOD SCIENCE & TECHNOLOGY | CARBOHYDRATE | FOODS | INSULIN | RESPONSES | OBESITY | NUTRITION & DIETETICS | FAT | PLASMA-GLUCOSE | CONSUMPTION | Breakfast foods | Cakes | Body weight | Pastries | Glycemic index | Sugar | Bread | Food
Journal Article
Journal of Immunology, ISSN 0022-1767, 07/2017, Volume 199, Issue 1, pp. 253 - 262
Chemokines have been shown to play immune-modulatory functions unrelated to steering cell migration. CXCL4 is a chemokine abundantly produced by activated...
Journal Article | Immunology | MHC CLASS-I | IMMUNE-RESPONSES | ENDOTHELIAL-CELLS | TOLL-LIKE RECEPTORS | SUBCELLULAR-LOCALIZATION | ANTIGEN PRESENTATION | IMMUNOLOGY | SYSTEMIC-SCLEROSIS | CHEMOKINE PLATELET-FACTOR-4 | PLATELET FACTOR-IV | CROSS-PRESENTATION | Antigens, CD - immunology | B7-2 Antigen - genetics | Immunoglobulins - immunology | Escherichia coli Infections - prevention & control | Interleukin-12 - genetics | Coculture Techniques | Dendritic Cells - immunology | Humans | Platelet Factor 4 - immunology | Dendritic Cells - physiology | Immunoglobulins - genetics | Antigens, CD - genetics | CD4-Positive T-Lymphocytes - physiology | Quinolines - pharmacology | CD4-Positive T-Lymphocytes - immunology | Platelet Factor 4 - pharmacology | Tumor Necrosis Factor-alpha - immunology | Dendritic Cells - drug effects | Cell Differentiation | Membrane Glycoproteins - immunology | B7-2 Antigen - immunology | Escherichia coli - physiology | Poly I-C - pharmacology | Lymphocyte Activation | Cells, Cultured | Escherichia coli Infections - microbiology | Imidazoles - pharmacology | CD8-Positive T-Lymphocytes - physiology | Membrane Glycoproteins - genetics | Phenotype | CD8-Positive T-Lymphocytes - drug effects | Interleukin-12 - immunology | Escherichia coli Infections - immunology | Genes, MHC Class I | Platelet Factor 4 - metabolism | Thiazoles - pharmacology | CD8-Positive T-Lymphocytes - immunology | CD4-Positive T-Lymphocytes - drug effects | Cell proliferation | CD86 antigen | Leukocyte migration | CD8 antigen | Antigen processing | Stimulation | Lymphocytes T | Interleukin 4 | Cell activation | Lymphocytes | Toll-like receptors | Immune system | Immune response | Dendritic cells | Immunomodulation | Secretion | Interleukin 12 | Exposure | T cell receptors | Poly (I:C) | CD4 antigen | CD83 antigen | Monocytes | Major histocompatibility complex | Systemic sclerosis | Internalization | γ-Interferon | Ligands | Interferon | Platelets | Cell migration | Chemokines
Journal Article | Immunology | MHC CLASS-I | IMMUNE-RESPONSES | ENDOTHELIAL-CELLS | TOLL-LIKE RECEPTORS | SUBCELLULAR-LOCALIZATION | ANTIGEN PRESENTATION | IMMUNOLOGY | SYSTEMIC-SCLEROSIS | CHEMOKINE PLATELET-FACTOR-4 | PLATELET FACTOR-IV | CROSS-PRESENTATION | Antigens, CD - immunology | B7-2 Antigen - genetics | Immunoglobulins - immunology | Escherichia coli Infections - prevention & control | Interleukin-12 - genetics | Coculture Techniques | Dendritic Cells - immunology | Humans | Platelet Factor 4 - immunology | Dendritic Cells - physiology | Immunoglobulins - genetics | Antigens, CD - genetics | CD4-Positive T-Lymphocytes - physiology | Quinolines - pharmacology | CD4-Positive T-Lymphocytes - immunology | Platelet Factor 4 - pharmacology | Tumor Necrosis Factor-alpha - immunology | Dendritic Cells - drug effects | Cell Differentiation | Membrane Glycoproteins - immunology | B7-2 Antigen - immunology | Escherichia coli - physiology | Poly I-C - pharmacology | Lymphocyte Activation | Cells, Cultured | Escherichia coli Infections - microbiology | Imidazoles - pharmacology | CD8-Positive T-Lymphocytes - physiology | Membrane Glycoproteins - genetics | Phenotype | CD8-Positive T-Lymphocytes - drug effects | Interleukin-12 - immunology | Escherichia coli Infections - immunology | Genes, MHC Class I | Platelet Factor 4 - metabolism | Thiazoles - pharmacology | CD8-Positive T-Lymphocytes - immunology | CD4-Positive T-Lymphocytes - drug effects | Cell proliferation | CD86 antigen | Leukocyte migration | CD8 antigen | Antigen processing | Stimulation | Lymphocytes T | Interleukin 4 | Cell activation | Lymphocytes | Toll-like receptors | Immune system | Immune response | Dendritic cells | Immunomodulation | Secretion | Interleukin 12 | Exposure | T cell receptors | Poly (I:C) | CD4 antigen | CD83 antigen | Monocytes | Major histocompatibility complex | Systemic sclerosis | Internalization | γ-Interferon | Ligands | Interferon | Platelets | Cell migration | Chemokines
Journal Article
Movement Disorders, ISSN 0885-3185, 08/2018, Volume 33, Issue 8, pp. 1331 - 1339
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 2017, Volume 69, Issue 9, pp. 1891 - 1902
OBJECTIVE: Plasmacytoid dendritic cells (PDCs) are a critical source of type I interferons (IFNs) that can contribute to the onset and maintenance of...
GENE | AUTOIMMUNITY | DISEASE | INTERFERON-PRODUCING CELLS | LUPUS-ERYTHEMATOSUS | IRF8 | CLASSIFICATION | RHEUMATOLOGY | NF-KAPPA-B | I INTERFERON | NUCLEIC-ACIDS | Up-Regulation | Scleroderma, Systemic - blood | Antigens, CD34 - metabolism | Epigenesis, Genetic | Humans | Middle Aged | Scleroderma, Systemic - genetics | Male | Case-Control Studies | Interferon-alpha - secretion | Adult | Female | MicroRNAs - blood | Dendritic Cells - metabolism | CD34 antigen | Target recognition | Dendritic cells | Pathogenesis | MiRNA | Homeostasis | Activation | Ribonucleic acid--RNA | Patients | Mimicry | Biological effects | Cell activation | Molecular modelling | Production methods | Systemic sclerosis | MicroRNAs | Fibrosis | Peripheral blood | Epigenetics | Skin diseases | Interferon | Lesions | In vitro methods and tests | Immune system
GENE | AUTOIMMUNITY | DISEASE | INTERFERON-PRODUCING CELLS | LUPUS-ERYTHEMATOSUS | IRF8 | CLASSIFICATION | RHEUMATOLOGY | NF-KAPPA-B | I INTERFERON | NUCLEIC-ACIDS | Up-Regulation | Scleroderma, Systemic - blood | Antigens, CD34 - metabolism | Epigenesis, Genetic | Humans | Middle Aged | Scleroderma, Systemic - genetics | Male | Case-Control Studies | Interferon-alpha - secretion | Adult | Female | MicroRNAs - blood | Dendritic Cells - metabolism | CD34 antigen | Target recognition | Dendritic cells | Pathogenesis | MiRNA | Homeostasis | Activation | Ribonucleic acid--RNA | Patients | Mimicry | Biological effects | Cell activation | Molecular modelling | Production methods | Systemic sclerosis | MicroRNAs | Fibrosis | Peripheral blood | Epigenetics | Skin diseases | Interferon | Lesions | In vitro methods and tests | Immune system
Journal Article
Development, ISSN 0950-1991, 06/2002, Volume 129, Issue 11, pp. 2773 - 2783
We have previously reported the origin of a class of skeletal myogenic cells from explants of dorsal aorta. This finding disagrees with the known origin of all...
Angiogenesis | Pericyte | Histogenesis | Mouse | Stem cells | Mesoderm | Quail | Chimera | Endothelium | stem cells | endothelium | pericyte | angiogenesis | BONE-MARROW | SATELLITE CELLS | DEVELOPMENTAL BIOLOGY | PDGF-B | mesoderm | histogenesis | quail | chimera | mouse | NEURAL STEM-CELLS | SKELETAL-MUSCLE | MUSCLE REGENERATION | IN-VIVO | ENDOTHELIAL-CELLS | MYOGENIC PROGENITORS | Coturnix | Cells, Cultured | Aorta - embryology | Mice, Transgenic | Mesoderm - cytology | Muscle, Smooth, Vascular - cytology | Reverse Transcriptase Polymerase Chain Reaction | Muscle, Smooth, Vascular - embryology | Animals | Cell Differentiation | Mice | Aorta - cytology | Cell Culture Techniques
Angiogenesis | Pericyte | Histogenesis | Mouse | Stem cells | Mesoderm | Quail | Chimera | Endothelium | stem cells | endothelium | pericyte | angiogenesis | BONE-MARROW | SATELLITE CELLS | DEVELOPMENTAL BIOLOGY | PDGF-B | mesoderm | histogenesis | quail | chimera | mouse | NEURAL STEM-CELLS | SKELETAL-MUSCLE | MUSCLE REGENERATION | IN-VIVO | ENDOTHELIAL-CELLS | MYOGENIC PROGENITORS | Coturnix | Cells, Cultured | Aorta - embryology | Mice, Transgenic | Mesoderm - cytology | Muscle, Smooth, Vascular - cytology | Reverse Transcriptase Polymerase Chain Reaction | Muscle, Smooth, Vascular - embryology | Animals | Cell Differentiation | Mice | Aorta - cytology | Cell Culture Techniques
Journal Article
The Lancet Neurology, ISSN 1474-4422, 07/2018, Volume 17, Issue 7, pp. 597 - 608
Most patients with Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies do not carry mutations in known disease-causing genes. The...
Journal Article | DIAGNOSIS | MULTICENTER | MANAGEMENT | VPS35 | GLUCOCEREBROSIDASE MUTATIONS | ASSOCIATION | CLINICAL NEUROLOGY | FEATURES | REVEALS | Parkinson Disease - complications | Genome-Wide Association Study | Humans | Middle Aged | RNA, Messenger - genetics | Male | Dementia - epidemiology | Parkinson Disease - genetics | Dementia - genetics | LDL-Receptor Related Proteins - genetics | Lewy Body Disease - epidemiology | Pluripotent Stem Cells - metabolism | Dementia - etiology | Lewy Body Disease - genetics | Pedigree | Brain - pathology | Parkinson Disease - epidemiology | Family | Female | Heterozygote | Italy | RNA, Messenger - chemistry | Chromosomes, Human, Pair 14 - genetics | Genetic Linkage | Genetic research | Genetic aspects | Analysis | Genomics | Dementia | Parkinson's disease | Laboratories | Neuropathology | Immunocytochemistry | Genes | Parkinsons disease | Aneurysm | Genomes | Proteins | Neurodegeneration | Autopsy | Dementia disorders | Aorta | Chromosome 14 | Movement disorders | Deoxyribonucleic acid--DNA | Linkage analysis | Neurodegenerative diseases | Therapeutic applications | Gene expression | Lewy bodies | Genetic variance | Pathology | Cycloheximide | Brain research | Molecular modelling | Pluripotency | mRNA stability | Neurologi | Clinical Medicine | Neurology | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article | DIAGNOSIS | MULTICENTER | MANAGEMENT | VPS35 | GLUCOCEREBROSIDASE MUTATIONS | ASSOCIATION | CLINICAL NEUROLOGY | FEATURES | REVEALS | Parkinson Disease - complications | Genome-Wide Association Study | Humans | Middle Aged | RNA, Messenger - genetics | Male | Dementia - epidemiology | Parkinson Disease - genetics | Dementia - genetics | LDL-Receptor Related Proteins - genetics | Lewy Body Disease - epidemiology | Pluripotent Stem Cells - metabolism | Dementia - etiology | Lewy Body Disease - genetics | Pedigree | Brain - pathology | Parkinson Disease - epidemiology | Family | Female | Heterozygote | Italy | RNA, Messenger - chemistry | Chromosomes, Human, Pair 14 - genetics | Genetic Linkage | Genetic research | Genetic aspects | Analysis | Genomics | Dementia | Parkinson's disease | Laboratories | Neuropathology | Immunocytochemistry | Genes | Parkinsons disease | Aneurysm | Genomes | Proteins | Neurodegeneration | Autopsy | Dementia disorders | Aorta | Chromosome 14 | Movement disorders | Deoxyribonucleic acid--DNA | Linkage analysis | Neurodegenerative diseases | Therapeutic applications | Gene expression | Lewy bodies | Genetic variance | Pathology | Cycloheximide | Brain research | Molecular modelling | Pluripotency | mRNA stability | Neurologi | Clinical Medicine | Neurology | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Clinical Reviews in Allergy & Immunology, ISSN 1080-0549, 12/2018, Volume 55, Issue 3, pp. 312–331 - 331
Systemic sclerosis (SSc) is a highly heterogeneous disease caused by a complex molecular circuitry. For decades, clinical and molecular research focused on...
Systemic sclerosis | Patient-reported outcomes (PROs) | Review | Personalized medicine | Immunology and Allergy | Journal Article | Clinical unmet needs | Allergology | Immunology | Medicine & Public Health | Internal Medicine | Signs and symptoms | Circuits | Environmental factors | Inflammation | Patients | Sclerosis | Complexity | Alterations | Experimental design | Fibrosis | Design of experiments
Systemic sclerosis | Patient-reported outcomes (PROs) | Review | Personalized medicine | Immunology and Allergy | Journal Article | Clinical unmet needs | Allergology | Immunology | Medicine & Public Health | Internal Medicine | Signs and symptoms | Circuits | Environmental factors | Inflammation | Patients | Sclerosis | Complexity | Alterations | Experimental design | Fibrosis | Design of experiments
Journal Article